FDA Inspection 1290514 — Fresenius Medical Care Deutschland Gmbh
The FDA completed an inspection of Fresenius Medical Care Deutschland Gmbh on June 29, 2023 in St. Wendel. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 29, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- St. Wendel (Germany)
Additional Details
Mutual Recognition Agreement (MRA)